Last reviewed dd mmm yyyy. Last edited dd mmm yyyy
NICE suggest with respect to use of mineralocorticoid receptor antagonists (MRA) in treating heart failure with reduced ejection fraction (1)
For patients who have had an acute MI and who have symptoms and/or signs of heart failure and left ventricular systolic dysfunction, treatment with an aldosterone antagonist licensed for post-MI treatment should be initiated within 3-14 days of the MI, preferably after ACE inhibitor therapy (2)
Notes:
Reference:
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.